First Turn Management »

Krystal Biotech shares owned by First Turn Management

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $30M 242k 124.06

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Krystal Biotech

venBio Select Advisor
Vanguard Group
Redmile Group
Frazier Life Sciences Management
Jennison Associates
Lord, Abbett & Co
Dimensional Fund Advisors
Ikarian Capital
Credit Suisse
T. Rowe Price Associates
Balyasny Asset Management
TimesSquare Capital Management
First Turn Management
Goldman Sachs Group
Jpmorgan Chase & Co

View all funds holding Krystal Biotech